menu search

EFTR / eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference

eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference
SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a biopharmaceutical company focused on pioneering the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that the Company will present and host 1x1 meetings at the 2022 BIO CEO & Investor Conference. Read More
Posted: Feb 9 2022, 16:00
Author Name: GlobeNewsWire
Views: 122475

EFTR News  

Best Penny Stocks To Buy Under $1.25? 3 To Watch Now

By PennyStocks
August 24, 2023

Best Penny Stocks To Buy Under $1.25? 3 To Watch Now

Are you looking for the best penny stocks to buy? You're not alone; many traders are showing a renewed interest in this exciting market. more_horizontal

Best Penny Stocks To Buy? 5 With Big News This Week

By PennyStocks
June 7, 2023

Best Penny Stocks To Buy? 5 With Big News This Week

Are you searching for some of the best penny stocks to buy now? I'm sure that if you're reading this article, that's something at the top of your mind more_horizontal

Why Is eFFECTOR Therapeutics (EFTR) Stock Up 75% Today?

By InvestorPlace
May 26, 2023

Why Is eFFECTOR Therapeutics (EFTR) Stock Up 75% Today?

EFFECTOR Therapeutics (NASDAQ: EFTR ) stock is taking off on Friday after the company reported positive data from a Phase 2 clinical trial. This inclu more_horizontal

eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences

By GlobeNewsWire
March 28, 2023

eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the developm more_horizontal

eFFECTOR Therapeutics to Present at 2023 BIO CEO & Investor Conference

By GlobeNewsWire
January 30, 2023

eFFECTOR Therapeutics to Present at 2023 BIO CEO & Investor Conference

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the developme more_horizontal

eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference

By GlobeNewsWire
February 9, 2022

eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference

SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a biopharmaceutical company focused on pio more_horizontal

eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference

By GlobeNewsWire
February 9, 2022

eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference

SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a biopharmaceutical company focused on pio more_horizontal

eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference

By GlobeNewsWire
February 9, 2022

eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference

SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a biopharmaceutical company focused on pio more_horizontal


Search within

Pages Search Results: